Peer Review History
| Original SubmissionSeptember 14, 2025 |
|---|
|
Dear Dr. Song, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Daniel Duck-Jin Hwang Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files 4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 5. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: This nationwide, population-based cohort study provides valuable epidemiologic insight into changing clinical practice patterns for primary angle-closure disease in Korea. While the study reports a negative correlation between cataract surgery and LPI volumes, the causal inference remains limited. The analysis is purely descriptive and does not adjust for potential confounders such as disease severity, socioeconomic factors, or the growing use of premium IOLs that may independently increase cataract surgery rates. Please revise the discussion to include the study limitation—specifically, the need to clarify that the findings are correlational and that potential confounding factors were not controlled for. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: This study demonstrates that the number of cataract surgeries increased while that of LPI decreased over the 6 years from 2016 to 2021, showing a significant negative correlation between the two based on data from the Korean National Health Information Database. The manuscript is well designed and well written. However, there are some points that need to be revised before it can be considered for publication. 1. The authors abruptly conclude a correlation between cataract surgeries and LPI procedures based on longitudinal observations of these two independent issues. However, they may have changed independently over the years. In fact, the decrease in the number of LPI procedures does not necessarily indicate a decrease in the occurrence of ACD. Accessibility to emergency care at night could also have differed during the study period compared to earlier periods. In addition, in cases of ACD, cataract surgery may have been performed soon after medical treatment for the management of ACD. These points should be considered in the Discussion section. 2. The authors mention that the significance of this study lies in the inclusion of the COVID-19 period. However, it is not clear why this is particularly meaningful for the present study. Although the data collection period included the COVID-19 years, the study also includes data from 2016, which was long before COVID-19 became a major issue. The authors should clarify the importance of this point. Reviewer #2: Woojin Kim et al. reported “Declining laser peripheral iridotomy for angle closure alongside rising cataract surgeries: A nationwide cohort study in South Korea.” The study showed a temporal association and demographic characteristics underlying the recent increase in cataract surgeries and the concurrent decline in LPI procedures in Korea. Notably, most patients who underwent LPI subsequently received cataract surgery within a relatively short interval, reflecting an evolving trend in the clinical management of PACD that may increasingly favor lens extraction over time. It is an interesting study; however, the study still needs to address some issues. - A person has two eyes. Please clarify how the codes distinguished between the right and left eyes. - The authors mentioned “suggesting that rising cataract surgeries likely contributed to the decline in LPI use.” However, since the analysis could not distinguish between the two eyes of a single patient and was based only on incidence data, it seems difficult to draw this causal conclusion. - The statement “The annual number of patients who underwent cataract surgery or LPI for PACG was analyzed, along with the rate of these procedures per 100,000 population” (lines 112-113) — does this refer to the rate among the entire Korean population, or only among those aged 65 years and older? - The increase in cataract surgeries and the decrease in LPI might have been affected by separate factors. To clarify this relationship, rather than analyzing only patients who underwent cataract surgery after LPI, it would be more appropriate to analyze, as in the studies cited by the authors (PMID: 24193602, 36252921), the annual trend of cataract surgery and LPI among patients diagnosed with PAC or PACG. - Systemic comorbidity was assessed using the Charlson comorbidity index (CCI). Please describe briefly what this index represents for readers unfamiliar with it. - Were there any age differences between patients who underwent cataract surgery after LPI and patients who underwent LPI alone? Such a difference could have influenced the results related to AMD and CCI scores. If there was an age difference, statistical adjustment would be required. - In Table 3, the meaning of the “P value for trend” is not clearly explained in the Results section. Please clarify what this P value indicates and why it was analyzed. - The following statement may be unnecessary: “Additionally, when analyzed by gender, negative correlations were observed in both females and males, with a stronger—though still non-significant—association in females (r = −0.771, P = 0.072; males: r = −0.543, P = 0.266).” Since these results are not statistically significant, it would be better to omit this part. - The authors mentioned an “ongoing trend toward earlier cataract surgery” (line 240). However, in Table 2, both the median and mean ages show little change over time, and the proportion of patients aged 65–74 years even tends to decrease. To substantiate this claim, data analysis should include a younger population (e.g., patients in their 50s), not only those aged 65 years and above. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Declining laser peripheral iridotomy for angle closure alongside rising cataract surgeries: A nationwide cohort study in South Korea PONE-D-25-49693R1 Dear Dr. Song, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Daniel Duck-Jin Hwang Academic Editor PLOS One Additional Editor Comments: The authors have revised and supplemented their manuscript appropriately. Thank you for the diligent revisions made to the manuscript in line with our comments. I truly appreciate your hard work and dedication to improving the manuscript. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Authors addressed replies well and revised their manuscript accordingly based on the reviewer's raised concerns. Reviewer #2: The revised manuscript has adequately addressed all reviewer's questions. No further comments for this manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-49693R1 PLOS One Dear Dr. Song, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Daniel Duck-Jin Hwang Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .